Current Clinical Trials
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
Sponsor: Merck & Co.
Indentifier #: NCT01254630
Title: V212-011, A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Srivatana M.D., Panit
Sub-Investigator(s):
Sponsor: Millenium Pharmaceutical
Indentifier #: NCT00931918
Title: C05013, An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients.
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: NCCTG
Title: N0392, Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG Clinical Trials
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sub-Investigator(s):
Sponsor: Santarus
Indentifier #: NCT01100112
Title: Protocol LSA81245vSSU, A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Budesonide MMX 9 mg Extended Release Tablets as Add-on Therapy in Patients with Active Mild of Moderate Ulcerative Colitis not Adequately Controlled on a Background Oral 5-ASA Regimen.
Department: Oncology
Diagnosis: Melanoma
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: NCCTG
Indentifier #: NCT00976573
Title: N0879, A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma